BerGenBio

AGM Information • Apr 5, 2018

BerGenBio ASA: Exercise of employee share options and increase of capital

BerGenBio ASA: Exercise of employee share options and increase of capital

Bergen, Norway, 5 April 2018 - The Board of Directors in BerGenBio ASA (the"Company") (OSE: BGBIO) has, to fulfil the Company's obligations under the option agreements, resolved to increase the Company's share capital by NOK 15,000 by issuance of 150,000 new shares. The new shares shall be subscribed for by an employee that wishes and is entitled to exercise options in accordance with the Company's option scheme. The subscription price shall be in accordance with the prevailing options price pursuant to the Company´s option scheme, ie NOK 16.01 - NOK 24.00 per share. The shares shall be subscribed for in a separate subscription document in the period from 5. April 2018 and up to and including 30. April 2018.

-End-

Contacts

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Rune Skeie

CFO, BerGenBio ASA

rune.skeie@bergenbio.com

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.